References
- World Health Organization (WHO) [webpage on the Internet]Hepatitis C fact sheet 164GenevaWHO2014 Available from: http://www.who.int/mediacentre/factsheets/fs164/enAccessed November 13, 2014
- SeeffLBNatural history of chronic hepatitis CHepatology2002365 Suppl 1S35S4612407575
- ChakETalalAHShermanKESchiffERSaabSHepatitis C virus infection in USA: an estimate of true prevalenceLiver Int20113181090110121745274
- DennistonMMJilesRBDrobeniucJChronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010Ann Intern Med2014160529330024737271
- Olysio (simeprevir) prescribing informationTitusville, NJJanssen Therapeutics122013
- SchinaziRHalfonPMarcellinPAsselahTHCV direct-acting antiviral agents: the best interferon-free combinationsLiver Int201434Suppl 1697824373081
- Sovaldi® (sofosbuvir) [prescribing information]Foster City, CAGilead Sciences, Inc2013
- LawitzESulkowskiMSGhalibRSimeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised studyLancet201438499561756176525078309
- Janssen Therapeutics [webpage on the Internet]Olysio® (simeprevir) gains additional FDA approval as once-daily, all-oral interferon- and ribavirin-free treatment option in combination with sofosbuvir for adults with genotype 1 chronic hepatitis C infectionTitusville, NJJanssen Therapeutics2014 Available from: http://www.janssentherapeutics.com/news-center/11052014prAccessed December 4, 2014
- American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (IDSA) [webpage on the Internet]Recommendations for testing, managing, and treating hepatitis C Available from: http://www.hcvguidelines.org/full-report-viewAccessed November 22, 2014
- KohCHellerTHaynes-WilliamsVLong-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapyAliment Pharmacol Ther201337988789423461575
- McHutchisonJGMannsMPatelKInternational Hepatitis Interventional Therapy GroupAdherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis CGastroenterology200212341061106912360468
- CVS HealthAnalysis of “real world” sovaldi (sofosbuvir) use and discontinuation ratesWoonsocket, RCVS Health2014 Available from: http://www.cvshealth.com/sites/default/files/hepatitisCutilization.pdfAccessed November 13, 2014
- JudayTRBaranRWManthenaSRWalkerDRImpact of pill count on medication adherence during the first 12 weeks of HIV antiviral treatment: implications for HCV treatmentPoster presented at: EASL 50th The International Liver Conference 2015April 22–26Vienna, Austria
- KohCLiangTJWhat is the future of ribavirin therapy for hepatitis C?Antiviral Res2014104343924468277
- ClarkVNelsonDRThe role of ribavirin in direct acting antiviral drug regimens for chronic hepatitis CLiver Int201232Suppl 110310722212579